Address And Details

1200 River Rd, Ste 1000 , Conschohoken, PA 19428
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The Nationwide Small Company Growth Fund seeks long-term capital appreciation. Current income is a secondary consideration in selecting portfolio investments. This objective may be changed by the Trust's Board of Trustees without shareholder approval upon 60 days written notice to shareholders. Under normal circumstances, the Fund invests at least 80% of its net assets in common stocks of small companies. The Fund employs a growth style of investing, as the subadvisor seeks to build a portfolio of exceptional small companies that have the wherewithal to become exceptional large companies. Specifically, the subadvisor seeks to identify publicly-traded companies early in their corporate life cycle that can produce exceptional long-term returns. For the purpose of the Fund, small companies are defined as companies with total operating revenues of $250 million or less at the time of initial investment. It is important to note that the Fund does NOT choose its portfolio companies based on a reference to market capitalization. Rather,the Fund's focus is on the revenue produced by the issuer of the securities. In selecting small companies with the potential to become successful large companies, the subadvisor analyzes the potential for: ¢sustainable revenue growth; adequate resources to establish and defend a viable product or service market, and market share; ¢sufficient profitability to support long-term growth and management skills and resources necessary to plan and execute a long-term growth plan.The subadvisor believes that: a sustained commitment to a portfolio of exceptional small companies will, over time, produce a significant investment return and an investment analysis that identifies and successfully evaluates those few small companies with the legitimate potential to become large companies can be a very rewarding investment strategy. Accordingly, the subadvis or employs analysis that contains elements of traditional dividend discount and earnings yield models. The subadvisor generally expects to hold securities for the long term in order to realize the potential rewards for incurring the risks associated with investing early in company's corporate life cycle. Nevertheless, the subadvisor sells securities when it believes their potential for future growth is diminished. The Fund may emphasize particular industry sectors or groupings, such as the software sector, and the percentage of the Fund's assets under normal circumstances, the Fund invests at least 80% of its net assets in common stocks of small companies. The Fund employs a growth style of investing, as the subadvisor seeks to build a portfolio of exceptional small companies that have the wherewithal to become exceptional large companies. Specifically, the subadvisor seeks to identify publicly-traded companies early in their corporate life cycle that can produce exceptional long-term returns. For the purpose of the Fund, small companies are defined as companies with total operating revenues of $250 million or less at the time of initial investment. It is important to note that the Fund does NOT choose its portfolio companies based on a reference to market capitalization. Rather, the Fund's focus is on the revenue produced by the issuer of the securities. In selecting small companies with the potential to become successful large companies, the subadvisor analyzes the potential for: sustainable revenue growth; adequate resources to establish and defend a viable product or service market, and market share; sufficient profitability to support long-term growth and management skills and resources necessary to plan and execute a long-term growth plan. The subadvisor believes that: a sustained commitment to a portfolio of exceptional small companies will, over time, produce a significant investment return and an investment analysis that identifies and successfully evaluates those few small companies with the legitimate potential to become large companies can be a very rewarding investment strategy. Accordingly, the subadvisor employs analysis that contains elements of traditional dividend discount and earnings yield models. The subadvisor generally expects to hold securities for the long term in order to realize the potential rewards for incurring the risks associated with investing early in company's corporate life cycle. Nevertheless, the subadvisor sells securities when it believes their potential for future growth is diminished. The Fund may emphasize particular industry sectors or groupings, such as the software sector, and the percentage of the Fund's assets.

Net Asset Value

as of 6:59 PM ET 09/17/2021

Performance

  • 1 Week
  • +0.28%
  • 1 Month
  • +4.08%
  • 3 Months
  • +3.61%
  • 1 Yr Return
  • +12.57%
  • 5 Yr Return
  • +82.55%

Equity Sector Breakdown

Technology 38.65%
Health 30.00%
IndustrialCyclical 7.47%
RetailTrade 6.78%
Services 1.16%
ConsumerDurables n/a
Energy n/a
Finance n/a
NonDurables n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 98.25%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 288.82 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -5.35 1.58 n/a
Beta 1.11 1.09 n/a
R Squared 0.68 0.61 n/a
Std Deviation 24.86 20.84 n/a
Sharpe Ratio 0.59 1.04 n/a

Purchase Information

as of 6:43 PM ET 09/16/2021
Minimum Initial $50000
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +19.28%
  • +25.74%
+19.28% +25.74%
3 Year
  • +12.43%
  • +16.33%
+12.43% +16.33%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • +18.31%
  • +18.31%
+18.31% +18.31%

Top 10 Holdings

Symbol Company Name % Of Assets
CGNX COGNEX CORP 4.69%
MANH MANHATTAN ASSOCIATES INC 4.63%
GKOS GLAUKOS CORPORATION 4.60%
ABMD ABIOMED INC 4.45%
ALRM ALARM COM HOLDINGS INC 4.42%
NEOG NEOGEN CORP 4.34%
ANSS ANSYS INC 4.32%
SMAR SMARTSHEET INC 4.17%
QTWO Q2 HOLDINGS INC 4.16%
PAYC PAYCOM SOFTWARE INC 3.91%

Recent Articles from TheStreet

Elon Musk Starlink Lead

SpaceX CEO Elon Musk Says Starlink Exits Beta Next Month

SpaceX CEO Elon Musk says the company’s Starlink high-speed internet service will come out of beta testing next month.

Wall Street Lead

Cramer: Using Short-Term Moves to Tweak Your Portfolio

Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.

10. Chemical & petrochemical pharma sh

Jensen: These Three Healthcare Stocks Are Worth a Look

Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.

18. Apple Inc. (AAPL)

Parus Files Second Patent Infringement Lawsuit Against Apple

Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.

12. Software engineer

Business Software Provider AvidXchange Files for IPO

Accounts payable software provider AvidXchange on Friday filed for a initial public offering.

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.